Skip Nav Destination
Issues
15 November 2013
-
Cover Image
Cover Image
Diaphanous-related formins create new and/or stabilize microfilament and microtubule structures that support polarized cell adhesion, migration, and division. GTP-bound Rho proteins activate these formins by direct binding. The molecular mechanism of Rho activation is through steric disruption of intramolecular interactions between Dia-inhibitory (DID) and Dia-autoregulatory (DAD) domains. Screening for compounds that block DID-DAD binding led to the discovery of intramimics, which are small molecules that interfere with autoinhibition, resulting in activation of cellular formins. Using immunofluorescence to detect detyrosinated microtubules (a trait of stabilized microtubules), this image illustrates microtubules stabilized by intramimic exposure. For details on the mechanism and pharmacologic impairment of tumor growth, see article by Lash and colleagues on page 6793. - PDF Icon PDF LinkTable of Contents
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Reviews
Integrated Systems and Technologies
A DNA Methylation Prognostic Signature of Glioblastoma: Identification of NPTX2-PTEN-NF-κB Nexus
Sudhanshu Shukla; Irene Rosita Pia Patric; Sivaarumugam Thinagararjan; Sujaya Srinivasan; Baisakhi Mondal; Alangar S. Hegde; Bangalore A. Chandramouli; Vani Santosh; Arimappamagan Arivazhagan; Kumaravel Somasundaram
Microenvironment and Immunology
Author Choice
Enhancement of Antitumor Immunity in Lung Cancer by Targeting Myeloid-Derived Suppressor Cell Pathways
Anandi Sawant; Cara C. Schafer; Tong Huan Jin; Jaroslaw Zmijewski; Hubert M. Tse; Justin Roth; Zhihuan Sun; Gene P. Siegal; Victor J. Thannickal; Stefan C. Grant; Selvarangan Ponnazhagan; Jessy S. Deshane
Molecular and Cellular Pathobiology
Hallmarks of Aromatase Inhibitor Drug Resistance Revealed by Epigenetic Profiling in Breast Cancer
Maurice P.H.M. Jansen; Theo Knijnenburg; Esther A. Reijm; Iris Simon; Ron Kerkhoven; Marjolein Droog; Arno Velds; Steven van Laere; Luc Dirix; Xanthippi Alexi; John A. Foekens; Lodewyk Wessels; Sabine C. Linn; Els M.J.J. Berns; Wilbert Zwart
The Transcription Factor IRF8 Counteracts BCR-ABL to Rescue Dendritic Cell Development in Chronic Myelogenous Leukemia
Tomoya Watanabe; Chie Hotta; Shin-ichi Koizumi; Kazuho Miyashita; Jun Nakabayashi; Daisuke Kurotaki; Go R. Sato; Michio Yamamoto; Masatoshi Nakazawa; Hiroyuki Fujita; Rika Sakai; Shin Fujisawa; Akira Nishiyama; Zenro Ikezawa; Michiko Aihara; Yoshiaki Ishigatsubo; Tomohiko Tamura
Author Choice
Intestinal GUCY2C Prevents TGF-β Secretion Coordinating Desmoplasia and Hyperproliferation in Colorectal Cancer
Ahmara V. Gibbons; Jieru E. Lin; Gilbert W. Kim; Glen P. Marszalowicz; Peng Li; Brian A. Stoecker; Erik S. Blomain; Satish Rattan; Adam E. Snook; Stephanie Schulz; Scott A. Waldman
CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer
Marine Malleter; Sébastien Tauzin; Alban Bessede; Rémy Castellano; Armelle Goubard; Florence Godey; Jean Levêque; Pascal Jézéquel; Loic Campion; Mario Campone; Thomas Ducret; Gaëtan MacGrogan; Laure Debure; Yves Collette; Pierre Vacher; Patrick Legembre
Therapeutics, Targets, and Chemical Biology
Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children
Joanna Triscott; Cathy Lee; Colleen Foster; Branavan Manoranjan; Mary Rose Pambid; Rachel Berns; Abbas Fotovati; Chitra Venugopal; Katrina O'Halloran; Aru Narendran; Cynthia Hawkins; Vijay Ramaswamy; Eric Bouffet; Michael D. Taylor; Ash Singhal; Juliette Hukin; Rod Rassekh; Stephen Yip; Paul Northcott; Sheila K. Singh; Christopher Dunham; Sandra E. Dunn
Crizotinib Inhibits Metabolic Inactivation of Gemcitabine in c-Met–driven Pancreatic Carcinoma
Amir Avan; Viola Caretti; Niccola Funel; Elena Galvani; Mina Maftouh; Richard J. Honeywell; Tonny Lagerweij; Olaf Van Tellingen; Daniela Campani; Dieter Fuchs; Henk M. Verheul; Gerrit-Jan Schuurhuis; Ugo Boggi; Godefridus J. Peters; Thomas Würdinger; Elisa Giovannetti
Chk1 Targeting Reactivates PP2A Tumor Suppressor Activity in Cancer Cells
Anchit Khanna; Otto Kauko; Camilla Böckelman; Anni Laine; Ilona Schreck; Johanna I. Partanen; Agnieszka Szwajda; Stefanie Bormann; Turker Bilgen; Merja Helenius; Yuba R. Pokharel; John Pimanda; Mike R. Russel; Caj Haglund; Kristina A. Cole; Juha Klefström; Tero Aittokallio; Carsten Weiss; Ari Ristimäki; Tapio Visakorpi; Jukka Westermarck
Cetuximab Response of Lung Cancer–Derived EGF Receptor Mutants Is Associated with Asymmetric Dimerization
Jeonghee Cho; Liang Chen; Naveen Sangji; Takafumi Okabe; Kimio Yonesaka; Joshua M. Francis; Richard J. Flavin; William Johnson; Jihyun Kwon; Soyoung Yu; Heidi Greulich; Bruce E. Johnson; Michael J. Eck; Pasi A. Jänne; Kwok-Kin Wong; Matthew Meyerson
Tumor and Stem Cell Biology
Retractions
Advertisement